Thursday, 17 August 2017

Biologics News

  • Singapore invests in microbial detection technology firm

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2015

    Singapore: Singapore Economic Development Board has invested in Rapid Micro Biosystems, a provider of automated, non-destructive, rapid microbial detection, to expand its global commercial ...Read more

  • Study: Telomerase causes inflammation in cancer

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 22 Nov, 2012

    Singapore: A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers. Chronic inflammation is now recognized as a key underlying cause fo...Read more

  • Genentech injects $285 mn in biologics manufacturing

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 14 Oct, 2013

    Singapore: Genentech, a member of the Roche Group, plans to invest more than USD285 million for the expansion of its biologics manufacturing facilities in Vacaville and Oceanside, Californi...Read more

  • Drug delivery device to self administer biologics

    Biologics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2014

    Singapore: US based Mystic Pharmaceuticals has developed a drug delivery device that enables patients to self administer drugs and biologics formulated as powders for systemic nasal, nose-t...Read more

  • Gene expression for personalized medicine: Report

    Biologics |  Analysis | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2014

    Singapore: Gene expression profiling can bring significant improvements to disease profiling and diagnoses based on genetic disposition and recent technology advances in this area are enabl...Read more

  • ParkwayHealth offers HBsAg Quantitative Assay

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013

    Singapore: ParkwayHealth Laboratory, a clinical laboratory service provider in Singapore, is to provide Hepatitis B Surface Antigen (HBsAg) quantitative assay.With HBsAg Quantitative Assay,...Read more

  • Rheumatoid arthritis mAb market to reach $15.7 bn

    Biologics |  Analysis | By BioSpectrum Bureau | 0 Comment | 15 Feb, 2013

    Singapore: Since 2004, the market for monoclonal antibodies (mAbs) in rheumatoid arthritis (RA) has experienced tremendous growth, and it is on the verge of entering a historically unpreced...Read more

  • Amgen & Astellas form JV, will co-develop biologics

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 30 May, 2013

    Singapore: US-based Amgen and Japanese firm Astellas Pharma have entered into a strategic alliance to co-develop and co-commercialize five Amgen pipeline medicines in Japan. The five medic...Read more

  • Diagnostic kit to assess kidney cancer treatment result

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2014

    Singapore: Researchers at Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed a molecular te...Read more

  • Singapore scientists find new pattern in immune cell mechanism

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 02 Oct, 2014

    Singapore: Scientists from A*STAR's Bioprocessing Technology Institute (BTI) have identified relationship between two cells which serve human body's natural defence mechanisms against disea...Read more

  • miRNA tools market clocked $110 mn in 2012: Frost

    Biologics |  Analysis | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2013

    Singapore: Rapid growth in microRNA (miRNA) research over the past two years, which is fuelled by its diagnostic and therapeutic potential, has led to the the global miRNA tools and service...Read more

  • China to offer personalized chemotherapy

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2014

    Singapore: China-based Fosun diagnostics and Saladax Biomedical announced the launch of MyCare assay tests for chemotherapy in China. Saladax Biomedical in partnership with Fosun diagnostic...Read more

  • Green Cross to set up cell therapy plant in China

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 30 Apr, 2015

    Singapore: Green Cross, South Korean biopharmaceutical company, is expanding its manufacturing base by building a new cell therapy manufacturing facility in Guizhou province of China. The n...Read more

  • Takeda partners with Monash University

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2014

    Singapore: The Japanese pharma major Takeda, recently announced that the company has entered into a strategic partnership with Monash Institute of Pharmaceutical Sciences (MIPS) at Monash U...Read more

  • Taiwan researchers find link between obesity and arterial stiffness

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 29 Dec, 2014

    Singapore: According to a recent research at Taiwan based National Cheng Kung University (NCKU), obesity leads to a reduction in the protein lysyl oxidase (LOX) which accelerates aortic agi...Read more

  • DNA repair drug could treat leukaemia: Singapore

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 25 Aug, 2014

    Singapore: A team of scientists at National University of Singapore (NUS) have discovered that a drug originally designed for killing a limited type of cancer cells with DNA repair defects ...Read more

  • Singapore's AYOXXA closes $12.2 mn funding round

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2014

    Singapore: Singapore and Germany based biotech company, AYOXXA Biosystems, has completed $12.28 million (€9 million) Series B financing round. AYOXXA Biosystems has developed a propr...Read more

  • Biosimilars to take over biologic market by 2019'

    Biologics |  Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2014

    Singapore: The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected compound annual growth rate (CAG...Read more

Orchard Therapeutics appoin...

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls